Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06804772 · ClinicalTrials.gov registry record · NA
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo
A NA study of Skin Aging, sponsored by Victoria Collotta.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06804772: Active NA study of Skin Aging, sponsored by Victoria Collotta.
NCT06804772 is a NA study of Skin Aging that is active but no longer recruiting, run by Victoria Collotta. The registered enrollment target is 15 participants, below the 74-participant average among 9 other Skin Aging trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06804772, a NA study of Skin Aging, is active but no longer recruiting, sponsored by Victoria Collotta.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
A clinical study with approximately 15 subjects, aged 35-65 years of age, who must have crow's feet and at least one other type of facial fine lines/wrinkles in order to evaluate the efficacy of Activated Silk™ 27P-α to improve the signs of aging, by comparing to a placebo.
Primary Outcome
Change in appearance of fine lines/wrinkles for subjects treated with Investigational Facial Serum #3 at Day 28 vs. Day 0
Conditions Studied
Interventions
- OTHER Investigational Facial Serum #1
- OTHER Investigational Facial Serum #2
- OTHER Investigational Facial Serum #3
Study Locations (1)
Massachusetts
- Evolved By Nature - Needham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-12-03 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What the registry record for NCT06804772 still lists
NCT06804772 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 74-participant average among 9 other Skin Aging trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Skin Aging appearing as the primary indexed condition, and to 3 interventions - of which Investigational Facial Serum #1 is the first listed.
NCT06804772 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06804772 about?
NCT06804772 is a clinical study titled "A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo". A clinical study with approximately 15 subjects, aged 35-65 years of age, who must have crow's feet and at least one other type of facial fine lines/wrinkles in order to evaluate the efficacy of Activated Silk™ 27P-α to improve the signs of aging, by comparing to a placebo.
What is the current status of trial NCT06804772?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-12-03. Estimated completion is 2025-01-31.
What conditions does trial NCT06804772 study?
This clinical trial studies the following conditions: Skin Aging.
What interventions are being tested in trial NCT06804772?
The interventions under investigation include: Investigational Facial Serum #1 (OTHER), Investigational Facial Serum #2 (OTHER), Investigational Facial Serum #3 (OTHER).
Who is sponsoring clinical trial NCT06804772?
This trial is sponsored by Victoria Collotta, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06804772 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06804772's enrollment target sits among peer trials
15 9th of 9 higher than 1 of 9 other Skin Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging
ACTIVE NOT RECRUITING · NA
-
Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health
COMPLETED · NA
-
Thermage CPT for Treatment of Facial and Neck Laxity
COMPLETED · NA
-
Relationship of Skin Related SNP to Topical Skin Care Product
COMPLETED · NA
-
A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Skinpen on Male and Female Subjects' Dorsal Hands as a Treatment of Hand Aging
COMPLETED · NA
-
Efficacy of a Dietary Supplement on Parameters of Skin Aging in Men and Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI